Major drug companies cap asthma medication costs at $35 per month

  • 📰 WGAL
  • ⏱ Reading Time:
  • 23 sec. here
  • 24 min. at publisher
  • 📊 Quality Score:
  • News: 90%
  • Publisher: 59%

Allergies Nouvelles

Allergy,Asthma,Astrazeneca

Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients, but critics argue it's only part of the solution to high drug prices.

Major pharmaceutical companies have agreed to cap out-of-pocket costs for some asthma patients at $35 per month, a move that offers relief but doesn't fully address the larger issue of high drug costs.Patient Kenny Mendez said an asthma attack is 'like breathing through a straw.''You're laboring, you're not getting a full breath,' Mendez said.'When you don't take your medication you can end up in the hospital, the emergency room or even die.

Bernie Sanders declared in March, reacting to the news that the companies capped their prices following pressure from the Senate Health, Education, Labor, and Pensions Committee he chairs.'Big pharma's able to charge Americans significantly higher prices and pad their profits,' President Joe Biden stated at a White House event in April, criticizing the practices he says pharmaceutical companies use to restrict access to their products.

 

Merci pour votre commentaire. Votre commentaire sera publié après examen.
Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

 /  🏆 331. in BE

Belgique Dernières Nouvelles, Belgique Actualités